0.70
price down icon1.46%   -0.0104
 
loading

Immunic Inc Borsa (IMUX) Ultime notizie

pulisher
Jun 17, 2025

Financial Metrics Check: Immunic Inc (IMUX)’s Ratios for Trailing Twelve Months - DWinneX

Jun 17, 2025
pulisher
Jun 11, 2025

Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of “Buy” by Brokerages - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Immunic Post-Readout: Reiterating Strong Buy As Big Drop Appears Unwarranted (NASDAQ:IMUX) - Seeking Alpha

Jun 09, 2025
pulisher
Jun 09, 2025

Millennium Management LLC Has $580,000 Stake in Immunic, Inc. (NASDAQ:IMUX) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Immunic completes Phase 3 multiple sclerosis trial enrollmentICYMI - Proactive financial news

Jun 07, 2025
pulisher
Jun 06, 2025

Immunic Therapeutics reaches major milestone with completion of ENSURE Trial Enrollment - Proactive financial news

Jun 06, 2025
pulisher
Jun 06, 2025

Immunic at Jefferies Conference: Promising MS Drug Insights By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 05, 2025

Immunic at Jefferies Conference: Promising MS Drug Insights - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

Small cap wrap: Midnight Sun Mining, Standard Uranium, Immunic, ReconAfrica... - Proactive Investors

Jun 05, 2025
pulisher
Jun 05, 2025

Market movers: Tesla, Verint, PVH, Immunic... - Proactive financial news

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic (IMUX) Receives Continued 'Buy' Rating from D. Boral Cap - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic (IMUX) Receives Continued 'Buy' Rating from D. Boral Capital | IMUX Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic completes patient enrollment in Phase 3 relapsing multiple sclerosis trials - Proactive financial news

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic Completes Enrollment in 2 Phase 3 Studies in Relapsing Multiple Sclerosis - MarketScreener

Jun 05, 2025
pulisher
Jun 05, 2025

IMUX: Promising Results of Vidofludimus Calcium in Multiple Scle - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS - The Malaysian Reserve

Jun 05, 2025
pulisher
Jun 05, 2025

Immunic Announces Completion of Enrollment for Both Phase 3 ENSU - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

IMUX Completes Enrollment for Phase 3 Trials in Multiple Sclerosis | IMUX Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Top Executives Make Bold Moves with Major Immunic Stock Purchases! - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Immunic Approves Equity Plan Amendment at Annual Meeting - TipRanks

Jun 04, 2025
pulisher
Jun 03, 2025

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering | IMUX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic Announces Closing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering - Longview News-Journal

Jun 03, 2025
pulisher
Jun 03, 2025

Immunic raises $65M in public offering to fund clinical trials - Proactive financial news

Jun 03, 2025
pulisher
Jun 02, 2025

Immunic to Participate in Investor, Scientific and Industry Conf - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Immunic to Participate in Investor, Scientific and Industry Conferences in June - The Malaysian Reserve

Jun 02, 2025
pulisher
Jun 02, 2025

Immunic releases June conference schedule - Proactive financial news

Jun 02, 2025
pulisher
May 30, 2025

Immunic Announces $65 Million Public Offering - TipRanks

May 30, 2025
pulisher
May 30, 2025

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - Eastern Progress

May 30, 2025
pulisher
May 30, 2025

Immunic Inc. prices $65 million public offering By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 30, 2025

Immunic (NASDAQ:IMUX) Price Target Lowered to $10.00 at D. Boral Capital - Defense World

May 30, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches $65M Public Offering, Shares Drop - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic Tumbles After Pricing $65 Million Offering of Warrants - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Un - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Small cap wrap: Fineqia, Synchronoss, Santacruz Silver, Immunic... - Proactive financial news

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Receives Target Price Adjustment from D. Boral Ca - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Receives Target Price Adjustment from D. Boral Capital | IMUX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Faces Price Target Reduction Amid Stock Offering | IMUX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches Public Offering with Warrant Options | I - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic shares fall 12% after pricing of $65 million underwritten public offering to fund trials - Seeking Alpha

May 29, 2025
pulisher
May 29, 2025

Immunic to raise up to $65M in underwritten public offering - Proactive Investors

May 29, 2025
pulisher
May 29, 2025

Immunic (IMUX) Launches Public Offering with Warrant Options | IMUX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Immunic Announces Pricing Of Oversubscribed $65 Million Underwritten Public Offering - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Immunic Inc. prices $65 million public offering - Investing.com

May 29, 2025
pulisher
May 29, 2025

Immunic, Inc. Announces Proposed Public Offering - Longview News-Journal

May 29, 2025
pulisher
May 28, 2025

Immunic launches public offering of warrants to fund clinical trials; shares down - MSN

May 28, 2025
pulisher
May 28, 2025

Immunic slides on planned equity raise - TradingView

May 28, 2025
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Capitalizzazione:     |  Volume (24 ore):